Drugs / 2-0, 3-0, Desulfated Heparin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT01843634 | Aug 2013 → Apr 2015 | acute myeloid leukemia | Jazz Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 2-0, 3-0, Desulfated Heparin | “A Pilot Study to Evaluate the Safety and Preliminary Evidence of a Therapeutic Effect of ODSH (2-0, 3-0, Desulfated Heparin) in Patients Receiving Induction or Consolidation...” NCT01843634 ↗ |
| Known as | ODSH | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01843634 ↗ |